Hans van Eenennaam

Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ.

Aduro BioTech, Inc. is a clinical-stage immunotherapy company, which engages in the discovery, development, and commercialization of therapies that transform the treatment of diseases, including cancer. Its technology platforms include STING Pathway Activator, B-select monoclonal antibody, and LADD, or Live, Attenuated, Double-Deleted Listeria monocytogenes. The company's platforms stimulate and/or regulate innate and adaptive immune responses, either as single agents or in combination with conventional therapies like chemotherapy and radiation as well as other novel immunotherapies. Aduro BioTech was founded in 2000 and is headquartered in Berkeley, CA.

N.V. Organon engages in the development, manufacture, and sale of prescription medicines. It offers products for cardiovascular diseases, fertility, gynecology, anesthesia, respiratory, consumer health care, neuroscience as well as immunology, animal health, and oncology. Its products include mometasone furoate inhalation powder, moxifloxacin, pegylated liposomal doxorubicin HCI, desogestrel, desloratadine, sun care, flu medicine, foot care, follitropin beta, formoterol fumarate inhalation powder, hormone therapy, and canine vaccines. The company was founded in 1923 and is headquartered in Oss, the Netherlands.

Part of Merck & Co., Inc., Merck Sharp & Dohme BV is a Dutch company that manufactures and distributes pharmaceutical products. The company is based in Haarlem, the Netherlands.

iSD Immunotech ApS develops immunoregulatory peptides and proteins. It conducts research and development on immunoregulatory peptides for possible applications and commercialization. The company was founded by Peter Samuel Wulff, Shervin Bahrami, Finn Skou Pedersen, Mogens Ryttergård Duch, Lars Jørgen Østergaard, Martin Tolstrup, and Martin Thygesen on August 9, 2007 and is headquartered in Aarhus, Denmark.

CatalYm GmbH specializes in catalyzing immunotherapy. The company is headquartered in Munich, Germany.

Lygature is a not-for-profit organization that drives the development of new medical solutions for patients by managing public-private partnerships involving academia, industry, and society. The non-profit company is based in Utrecht, Netherlands, and provides specialized support for research consortia to address unmet medical needs worldwide. The Dutch company combines proprietary resources to find solutions for unmet medical needs by securing partners, acquiring funding, and sharing risks and resources. Lygature operates in the health innovation sector, where patients, doctors, healthcare providers, methodologists, CE-experts, entrepreneurs, insurers, investors, and regulatory authorities all contribute to delivering better medical devices faster. Lygature manages large multistakeholder partnerships in the life sciences and has 15 years of experience in starting and managing such partnerships.

Sairopa B V is a Dutch company that develops medicines and operates as an investment holding company.